BRIEF published on 05/22/2024 at 15:03, 4 months 7 days ago The Vanguard Group, Inc. Discloses Position on Redrow plc Takeover Code Vanguard Group Shareholding SEC Filing Redrow Plc
PRESS RELEASE published on 05/22/2024 at 15:02, 4 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corporation The Vanguard Group, Inc. discloses a 11.22% interest in Quanex Building Products Corporation as of 21 May 2024. Dealings include the sale of 602 common securities at $32.78 USD per unit on 22 May 2024 Securities Disclosure Vanguard Group Inc. Dealings Quanex Building Products Corporation
PRESS RELEASE published on 05/22/2024 at 15:02, 4 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company The Vanguard Group, Inc. discloses 11.74% stake in International Paper Company on 21st May 2024 as per Rule 8.3 of the Takeover Code The Vanguard Group, Inc. Rule 8.3 Takeover Code Stake Disclosure International Paper Company
PRESS RELEASE published on 05/22/2024 at 15:01, 4 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Hipgnosis Songs Fund Limited The Vanguard Group, Inc. discloses 1.20% ownership of Hipgnosis Songs Fund Limited. Form 8.3 filing as per the Takeover Code The Vanguard Group, Inc. Form 8.3 Ownership Disclosure Hipgnosis Songs Fund Limited 1.20%
PRESS RELEASE published on 05/22/2024 at 15:00, 4 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Balanced Commercial Property Trust Limited The Vanguard Group, Inc. discloses 4.16% stake in Balanced Commercial Property Trust Limited. Details in Form 8.3 filing Form 8.3 The Vanguard Group Inc. Financial Securities Stake Disclosure Balanced Commercial Property Trust Limited
PRESS RELEASE published on 05/22/2024 at 14:59, 4 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Darktrace plc The Vanguard Group, Inc. discloses a 2.84% interest in Darktrace plc's 1p ordinary securities. Purchase of 5,400 securities at 5.93 GBP per unit Securities Disclosure Vanguard Group Inc. Purchase Darktrace Plc
PRESS RELEASE published on 05/22/2024 at 14:59, 4 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc The Vanguard Group, Inc. discloses a 4.15% stake in Network International Holdings plc. Details in Form 8.3 filing. Contact: Shawn Acker Form 8.3 Network International Holdings Plc The Vanguard Group Inc. Stake Disclosure Shawn Acker
PRESS RELEASE published on 05/22/2024 at 14:58, 4 months 7 days ago Form 8.3 - The Vanguard Group, Inc.: Redrow plc The Vanguard Group, Inc. discloses 3.99% stake in Redrow plc. Purchase of 3,568 ordinary shares at 7.25 GBP per unit. Other details disclosed as per Rule 8.3 Securities Disclosure The Vanguard Group Redrow Plc Stake
BRIEF published on 05/22/2024 at 14:56, 4 months 7 days ago The Vanguard Group Discloses Position in Virgin Money UK plc Securities Disclosure Takeover Code Vanguard Group Virgin Money UK
BRIEF published on 05/22/2024 at 14:55, 4 months 7 days ago The Vanguard Group Discloses Position in Wood Group (John) plc Securities Disclosure Takeover Code Vanguard Wood Group
Published on 09/28/2024 at 02:06, 1 day 19 hours ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 1 day 19 hours ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day 21 hours ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/29/2024 at 19:15, 2 hours 6 minutes ago EQS-Adhoc: BayWa AG: Extension of the standstill agreements and increase in bridge financing
Published on 09/28/2024 at 14:01, 1 day 7 hours ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 22 hours ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 23 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 2 days 2 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 17:45, 2 days 3 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 3 days 3 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 3 days 3 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 3 days 3 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024